NCT01582230 Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01580852 The Effects of Immersion in Dead Sea Water on Glucose Levels in Type 2 Diabetes Mellitus Patients Status COMPLETED Phase NA
NCT01576887 A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis Status WITHDRAWN Phase PHASE2
NCT01572649 Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01571622 Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 Diabetes Status COMPLETED Phase NA
NCT01568125 Effect of Incretin-related Drugs on Dietary Intake in Japanese Patients With Type 2 Diabetes Mellitus Status UNKNOWN Phase N/A
NCT01560546 Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE4
NCT01558271 A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01557972 Long-term of 10 Years Results of a Prospective Longitudinal Study Status UNKNOWN Phase N/A
NCT01557504 A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296) Status COMPLETED Phase PHASE1
NCT01555164 A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone Status COMPLETED Phase PHASE3
NCT01555008 Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment Status COMPLETED Phase PHASE1
NCT01547897 NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria Status COMPLETED Phase PHASE2
NCT01546597 Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine Status COMPLETED Phase PHASE1
NCT01546558 Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg Status COMPLETED Phase PHASE1